Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Post-Mkt 03-04 19:55:21 EST

81.82

-0.10

-0.12%

盘后81.60

-0.22-0.27%

18:36 EST

High81.95	Low80.81	Vol1.51M
Open81.66	D1 Closing81.92	Amplitude1.40%
Mkt Cap9.82B	Tradable Cap8.87B	Total Shares120.03M
T/O123.09M	T/O Rate1.39%	Tradable Shares108.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":81.82,"timestamp":1772658000000,"preClose":81.92,"halted":0,"volume":1510062,"hourTrading":{"tag":"盘后","latestPrice":81.6,"preClose":81.82,"latestTime":"18:36 EST","volume":29603,"amount":2422095.25775,"timestamp":1772667413623,"change":-0.22,"changeRate":-0.002689,"amplitude":0.010132},"delay":0,"changeRate":-0.001220703125000104,"floatShares":108366822,"shares":120028300,"eps":1.77,"marketStatus":"Post-Mkt","change":-0.1,"latestTime":"03-04 19:55:21 EST","open":81.66,"high":81.95,"low":80.805,"amount":123086391.87084,"amplitude":0.013977,"askPrice":82.32,"askSize":4,"bidPrice":80.99,"bidSize":30,"shortable":3,"etf":0,"ttmEps":1.77,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772672400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":81.92,"dividendRate":0.037656,"preHourTrading":{"tag":"盘前","latestPrice":82.27,"preClose":81.92,"latestTime":"09:16 EST","volume":24,"amount":1973.21484,"timestamp":1772633808004,"change":0.35,"changeRate":0.004272,"amplitude":0.015442},"postHourTrading":{"tag":"盘后","latestPrice":81.6,"preClose":81.82,"latestTime":"18:36 EST","volume":29603,"amount":2422095.25775,"timestamp":1772667413623,"change":-0.22,"changeRate":-0.002689,"amplitude":0.010132},"volumeRatio":1.167111,"impliedVol":0.1707,"impliedVolPercentile":0.0598},"requestUrl":"/m/hq/s/ADC/tweets","defaultTab":"tweets","newsList":[{"id":"2617569565","title":"Press Release: Enhabit Reports Fourth Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2617569565","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617569565?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:10","pubTimestamp":1772658600,"startTime":"0","endTime":"0","summary":"Enhabit, Inc. , a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025.\"Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA,\" said Barb Jacobsmeyer, CEO and president of Enhabit. \"The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026.\". --  Net loss attributable to Enhabit, Inc. of $38.7 million. --  Announced entry into a definitive agreement  to. be acquired by Kinderhook Industries, LLC  for $13.80 per. --  On Feb. 26, 2026, the company entered into an amended and restated. credit agreement with a maturity date of February 2031 that consists of a. year; continued stabilization of Medicare ADC decline, down 4.0% year. --  Ho","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4080","BK4196","EHAB","ADC"],"gpt_icon":0},{"id":"2616314897","title":"Tong Hsing Electronic Partners with SixSense on AI Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2616314897","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616314897?lang=en_us&edition=fundamental","pubTime":"2026-03-03 15:55","pubTimestamp":1772524500,"startTime":"0","endTime":"0","summary":"SINGAPORE, March 3, 2026 /PRNewswire/ -- TongHsing Electronic, a global leader in semiconductor assembly and testing services, today announced a strategic collaboration with Singapore-based AI solutions provider SixSense, following a comprehensive market evaluation. The partnership aims to advance Tong Hsing's smart factory initiatives, with an initial focus on AI-driven defect classification  in manufacturing processes.As semiconductor manufacturing becomes increasingly complex and high-volume, traditional manual defect inspection and classification methods face growing challenges in terms of labor cost, consistency, and efficiency. After evaluating multiple solutions, Tong Hsing Electronic selected SixSense for its strong performance in classification accuracy, deployment flexibility, and seamless integration with existing production systems - aligning closely with the company's long-term digital transformation and smart manufacturing strategy.By adopting SixSense's AI-powered ADC so","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2920083/THEIL_company_photo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2920083/THEIL_company_photo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/tong-hsing-electronic-partners-with-sixsense-on-ai-solutions-302702186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4528","BK4543","BK4585","BK4551","ADC.AU","BK4588","BK4023","ADC","BK7095","BK4587","BK4231","AIYY"],"gpt_icon":1},{"id":"2616940367","title":"Horizon Oil Says Northern Territory Authorities Agree To Extend Deadline For Execution Of Binding Gas Sales Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2616940367","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616940367?lang=en_us&edition=fundamental","pubTime":"2026-03-03 07:24","pubTimestamp":1772493840,"startTime":"0","endTime":"0","summary":"Horizon Oil  and its Mereenie joint venture partners agreed with Northern Territory's Power and Water Corporation to extend the deadline to execute a binding gas sales agreement to March 24 from Monday, according to a Tuesday Australian bourse filing.Horizon and its joint venture partners had entered a binding letter of intent with Northern Territory's Power and Water Corporation to document and execute gas supply agreements consistent with conditional gas supply term sheets that will see uncontracted firm gas production from Mereenie sold through to 2034.Horizon has a 25% stake in the Mereenie field, along with other joint venture participants, Central Petroleum, Echelon Mereenie, Horizon Australia Energy, and Cue Mereenie.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADC"],"gpt_icon":0},{"id":"2616356800","title":"'The Regime Sure Did Change,' Says Pete Hegseth About Iran—But Do Prediction Markets Agree?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616356800","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616356800?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:43","pubTimestamp":1772462580,"startTime":"0","endTime":"0","summary":"Defense Secretary Hegseth praised US and Israel's deadly joint strikes on Iran, predicting an eventual nuclear deal but uncertain regime change.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/02/Washington--Jan-30-2025-Secretary-Of-Def.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/02/Washington--Jan-30-2025-Secretary-Of-Def.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/prediction-markets/26/03/50966623/the-regime-sure-did-change-says-pete-hegseth-about-iran-but-do-prediction-markets-agree","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/prediction-markets/26/03/50966623/the-regime-sure-did-change-says-pete-hegseth-about-iran-but-do-prediction-markets-agree","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["ADC","EQNR","BK4080","BK4585","BK4588","BK4231","BK4201"],"gpt_icon":0},{"id":"2616682083","title":"A Look At Agree Realty (ADC) Valuation After Recent Share Price Momentum And Premium P/E Multiple","url":"https://stock-news.laohu8.com/highlight/detail?id=2616682083","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616682083?lang=en_us&edition=fundamental","pubTime":"2026-03-01 20:16","pubTimestamp":1772367380,"startTime":"0","endTime":"0","summary":"Agree Realty (ADC) has drawn attention after its recent share performance, with the stock last closing at $80.48. For income focused investors, the real estate investment trust’s profile may warrant a closer look.\nSee our latest analysis for Agree Realty.\nThe recent 11.8% 1 month share price return, on top of an 11.6% year to date share price return, sits alongside a 5 year total shareholder return of 54.4%, suggesting momentum has been building over both shorter and longer horizons.\nIf this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/a-look-at-agree-realty-adc-valuation-after-recent-share-pric","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/a-look-at-agree-realty-adc-valuation-after-recent-share-pric","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CFA.SI","BK7095","BK4231","ADC.AU","ADC","BK4080"],"gpt_icon":0},{"id":"2616826018","title":"Will Iran-US Agree To A Nuclear Deal? Here's What The Prediction Market Thinks","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826018","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616826018?lang=en_us&edition=fundamental","pubTime":"2026-03-01 16:44","pubTimestamp":1772354640,"startTime":"0","endTime":"0","summary":"U.S. and Israel strike Iran, killing Supreme Leader Khamenei and other leaders. Prediction markets optimistic about nuclear deal.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/01/Iran-Map--Coronavirus-In-Iran--Coranavir.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/01/Iran-Map--Coronavirus-In-Iran--Coranavir.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/03/50953906/will-iran-us-agree-to-a-nuclear-deal-heres-what-the-prediction-market-thinks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/03/50953906/will-iran-us-agree-to-a-nuclear-deal-heres-what-the-prediction-market-thinks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2616530828","title":"Assessing WuXi XDC Cayman (SEHK:2268) Valuation After New Earendil Labs ADC Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2616530828","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616530828?lang=en_us&edition=fundamental","pubTime":"2026-03-01 09:24","pubTimestamp":1772328295,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman (SEHK:2268) just expanded its ADC platform reach as Earendil Labs secured an exclusive global license to the WuXiTecan-2 payload-linker technology, structured with upfront, milestone and royalty economics.\nSee our latest analysis for WuXi XDC Cayman.\nThe Earendil Labs agreement, which highlights WuXi XDC Cayman’s ADC and payload platform, comes as the shares trade at HK$63.15, with a 1 day share price return of 8.23%, a 30 day share price return of 2.02%, and a 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/assessing-wuxi-xdc-cayman-sehk2268-valuation-after-new-earen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2268/wuxi-xdc-cayman-shares/news/assessing-wuxi-xdc-cayman-sehk2268-valuation-after-new-earen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1141","ADC","LU2488822045.USD","02268","DCF","SG9999014674.SGD","BK4231","BK4080"],"gpt_icon":0},{"id":"2614611859","title":"ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2614611859","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614611859?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:00","pubTimestamp":1772197200,"startTime":"0","endTime":"0","summary":"- Clinical development for both the investigational CD47-inhibitor evorpacept and the novel EGFR-targeted antibody-drug conjugate ALX2004 remains on track following strong 2025 execution; company anti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/27/3246481/0/en/ALX-Oncology-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","CRC","IE00BD4GTT62.SGD","BK4231","SITC","IE00BMG7P694.USD","BK4213","BK4080","IE00BMG7P926.USD","IE00BMG7P587.USD","PFS","BK4144","BK4211","ASH","OS","BK4225","BK4195","TRP","HR","LU0266512127.USD","LU0456854461.SGD","IE00BD4GTV84.USD","BK4109","BK4097","BK4203","ORR","BK4566","IE00BMG7P819.SGD","LU2463526074.USD","ADC","IE00BD4GTW91.USD","IE00BMG7P702.HKD","ALX","BK4161"],"gpt_icon":0},{"id":"2614072680","title":"BRIEF-Agree Realty Enters Forward Sale Agreements For $623 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614072680","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614072680?lang=en_us&edition=fundamental","pubTime":"2026-02-27 06:23","pubTimestamp":1772144632,"startTime":"0","endTime":"0","summary":"BRIEF-Agree Realty Enters Forward Sale Agreements For $623 Million - SEC FilingFeb 26  - Agree Realty Corp ADC.N:AGREE REALTY CORP - ENTERS FORWARD SALE AGREEMENTS FOR $623 MILLION - SEC FILINGSource text: [ID:n0000917251-26-000017]Further company coverage: ADC.N ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZM24A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2614207104","title":"Agree Realty Corp - Enters Forward Sale Agreements for $623 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614207104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614207104?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:54","pubTimestamp":1772142884,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nFWN3ZM24A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","ADC","BK4231"],"gpt_icon":0},{"id":"2614041765","title":"Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2614041765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614041765?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:30","pubTimestamp":1772109000,"startTime":"0","endTime":"0","summary":"Established partnership with Kelun-Biotech expanding pipeline and accelerating combination strategy with CR-001, PD-1 x VEGF bispecific antibody, and multiple ADCs ASCEND Phase 1/2 global clinical tri","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/26/3245470/0/en/Crescent-Biopharma-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1223083913.SGD","BK4231","BK4588","ADC","BK4080","IND","LABU","LU1223082519.USD","BK4585","CDE","LU1223082196.USD","BK4017"],"gpt_icon":0},{"id":"2614726515","title":"Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2614726515","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614726515?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:00","pubTimestamp":1771966800,"startTime":"0","endTime":"0","summary":"OJEMDA 2025 momentum reflected by Q4 and full year net product revenues of $52.8 million and $155.4 million, respectively 2026 U.S. net product revenue projected at $225 - $250 million  Expanded pipel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3244006/0/en/Day-One-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Reaffirms-2026-Outlook-and-Revenue-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2614440597","title":"Trump Will Reportedly Not Pardon Sam Bankman-Fried, But Do Prediction Markets Agree?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614440597","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614440597?lang=en_us&edition=fundamental","pubTime":"2026-02-25 03:07","pubTimestamp":1771960020,"startTime":"0","endTime":"0","summary":"The White House has two words for Sam Bankman-Fried: no pardon.\n\n\n\nThe convicted FTX fraudster has mounted a MAGA charm offensive from federal prison, dictating pro-Trump posts through Bureau of Prisons-approved phone calls to a proxy who publishes them on X.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/24/Sam-Bankman-Fried.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/24/Sam-Bankman-Fried.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/prediction-markets/26/02/50828459/trump-will-reportedly-not-pardon-sam-bankman-fried-but-do-prediction-markets-agree","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/prediction-markets/26/02/50828459/trump-will-reportedly-not-pardon-sam-bankman-fried-but-do-prediction-markets-agree","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2613438237","title":"Helix BioPharma Showcases CEACAM6-Targeted ADC Advances at World ADC London","url":"https://stock-news.laohu8.com/highlight/detail?id=2613438237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613438237?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:02","pubTimestamp":1771945354,"startTime":"0","endTime":"0","summary":"The latest update is out from Helix BioPharma ( ($TSE:HBP) ). Helix BioPharma unveiled new data on its CEACAM6-directed antibody-drug conjugate pro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/helix-biopharma-showcases-ceacam6-targeted-adc-advances-at-world-adc-london?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/helix-biopharma-showcases-ceacam6-targeted-adc-advances-at-world-adc-london?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2613797474","title":"Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2613797474","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613797474?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:00","pubTimestamp":1771916400,"startTime":"0","endTime":"0","summary":"Experimental data from FAP-Exd (AVA6103) demonstrates a more favorable profile compared to the marketed Antibody Drug Conjugate (ADC) Enhertu Clinical trial with AVA6103 is expected to be initiated in","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243168/0/en/Avacta-s-pre-CISION-Mechanism-for-Payload-Delivery-Shows-Key-Advantages-Compared-to-an-Antibody-Drug-Conjugate-in-Innovative-AI-Driven-Analysis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","PK","ADC","BK4123","BK4218","BK4231","PDC","BK4181"],"gpt_icon":0},{"id":"2613678627","title":"Analysts Offer Insights on Real Estate Companies: Tanger (SKT), UDR (UDR) and Agree Realty (ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613678627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613678627?lang=en_us&edition=fundamental","pubTime":"2026-02-24 14:41","pubTimestamp":1771915261,"startTime":"0","endTime":"0","summary":"Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Tanger (SKT – Research Report), UDR (UDR – Resear...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-tanger-skt-udr-udr-and-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-tanger-skt-udr-udr-and-agree-realty-adc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4585","SKT","UDR","BK4231","BK4215","ADC","BK4588"],"gpt_icon":0},{"id":"2613022784","title":"ADC Therapeutics Amends Royalty Deal, Issues New Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2613022784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613022784?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:49","pubTimestamp":1771850988,"startTime":"0","endTime":"0","summary":"ADC Therapeutics ( ($ADCT) ) has issued an update. On February 18, 2026, ADC Therapeutics amended its 2021 royalty-based funding agreement with ent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adc-therapeutics-amends-royalty-deal-issues-new-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adc-therapeutics-amends-royalty-deal-issues-new-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4231","BK4139","ADC","BK4539","BK4007","BK4080"],"gpt_icon":0},{"id":"2613630789","title":"Agree Realty Corp : Bmo Raises Target Price to $86 From $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2613630789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613630789?lang=en_us&edition=fundamental","pubTime":"2026-02-23 19:40","pubTimestamp":1771846805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nFWN3ZJ0NB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","ADC","BK4231"],"gpt_icon":0},{"id":"1192115369","title":"BIOKIN's EGFR×HER3 Bispecific ADC Iza-bren Meets Primary Endpoints in Phase III Trial for Advanced Triple-Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1192115369","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192115369?lang=en_us&edition=fundamental","pubTime":"2026-02-23 17:00","pubTimestamp":1771837219,"startTime":"0","endTime":"0","summary":"Sichuan Biokin Pharmaceutical Co., Ltd. (688506.SH) announced that an interim analysis of the Phase III clinical trial for iza-bren, an EGFR×HER3 bispecific antibody-drug conjugate (ADC), in patients...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02615","III","ADC","BK4080","688506","91194","BK4134","BK0239","BK4231"],"gpt_icon":0},{"id":"2613202928","title":"U.S. RESEARCH ROUNDUP-Akamai Technologies, Albemarle, Nordson","url":"https://stock-news.laohu8.com/highlight/detail?id=2613202928","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613202928?lang=en_us&edition=fundamental","pubTime":"2026-02-23 15:27","pubTimestamp":1771831633,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Akamai Technologies, Albemarle, NordsonFeb 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akam","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL4N3ZJ0D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAVA","GOOGL","ALB","ASAN","BMY","LEU","BLDR","CVNA","AMDL","ARMP","BURL","AMZN","TGT","AMD","OBDC","AIR","BSY","CAR","BKNG","ACLX","BBDC","AKAM","BXP","AMDU","BMNZ","ADBE","AD","AMDY","CWST","CVNX","ARDX","LNT","ACAD","CE","DAMD","BMNR","ALBG","BBY","CBRE","MO","ADSK","BKNU","OTF","CVNY","AJG","ANF","BBWI","BMNU","ADC","AXGN"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":0.0336},{"period":"1month","weight":0.1342},{"period":"3month","weight":0.1},{"period":"6month","weight":0.1378},{"period":"1year","weight":0.1058},{"period":"ytd","weight":0.1373}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0052},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.1654},{"period":"ytd","weight":-0.0023}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.002186},{"month":3,"riseRate":0.59375,"avgChangeRate":0.015371},{"month":4,"riseRate":0.580645,"avgChangeRate":0.002795},{"month":5,"riseRate":0.5,"avgChangeRate":0.015633},{"month":6,"riseRate":0.65625,"avgChangeRate":0.010123},{"month":7,"riseRate":0.65625,"avgChangeRate":0.022845},{"month":8,"riseRate":0.46875,"avgChangeRate":0.002201},{"month":9,"riseRate":0.46875,"avgChangeRate":-0.006321},{"month":10,"riseRate":0.5625,"avgChangeRate":-0.000339},{"month":11,"riseRate":0.65625,"avgChangeRate":0.003584},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}